Correlation Between GenMont Biotech and CHC Healthcare

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GenMont Biotech and CHC Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GenMont Biotech and CHC Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GenMont Biotech and CHC Healthcare Group, you can compare the effects of market volatilities on GenMont Biotech and CHC Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GenMont Biotech with a short position of CHC Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of GenMont Biotech and CHC Healthcare.

Diversification Opportunities for GenMont Biotech and CHC Healthcare

0.45
  Correlation Coefficient

Very weak diversification

The 3 months correlation between GenMont and CHC is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding GenMont Biotech and CHC Healthcare Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CHC Healthcare Group and GenMont Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GenMont Biotech are associated (or correlated) with CHC Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CHC Healthcare Group has no effect on the direction of GenMont Biotech i.e., GenMont Biotech and CHC Healthcare go up and down completely randomly.

Pair Corralation between GenMont Biotech and CHC Healthcare

Assuming the 90 days trading horizon GenMont Biotech is expected to generate 4.18 times less return on investment than CHC Healthcare. But when comparing it to its historical volatility, GenMont Biotech is 1.45 times less risky than CHC Healthcare. It trades about 0.05 of its potential returns per unit of risk. CHC Healthcare Group is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  4,190  in CHC Healthcare Group on December 30, 2024 and sell it today you would earn a total of  870.00  from holding CHC Healthcare Group or generate 20.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

GenMont Biotech  vs.  CHC Healthcare Group

 Performance 
       Timeline  
GenMont Biotech 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in GenMont Biotech are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, GenMont Biotech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
CHC Healthcare Group 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in CHC Healthcare Group are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, CHC Healthcare showed solid returns over the last few months and may actually be approaching a breakup point.

GenMont Biotech and CHC Healthcare Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GenMont Biotech and CHC Healthcare

The main advantage of trading using opposite GenMont Biotech and CHC Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GenMont Biotech position performs unexpectedly, CHC Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CHC Healthcare will offset losses from the drop in CHC Healthcare's long position.
The idea behind GenMont Biotech and CHC Healthcare Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity